April 1, 2000
| Article
Editor’s Note: In December 1999, the Food and Drug Administration approved a new preparation for the topical treatment of onychomychosis, which is by definition a fungus infection of the nail and would include both fingernails and toenails. The product, named Penlac Nail Lacquer Topical Solution 8%, was developed by Europe’s Aventis Pharma and is being marketed in the United States by Pennsylvania-based Dermik Laboratories, a unit of Aventis. At press time, manufacturers said the prescription drug would begin selling this spring. Since up until the approval of this drug the FDA had prohibited companies from claiming topical antifungals worked on nails, we asked Dr. Richard Scher to comment on the approval of the first topical treatment approved for treating fingernail and toenail fungus in the United States.
April 1, 2000
| Article
Clinical trials demonstrate that the prescription nail lacquer does penetrate the nail lacquer does penetrate the nail, enabling it to get to the fungus, which begins and is active in the skin underneath the nail bed.
Keywords: antifungals fungus treatments Penlac
April 1, 2000
| Article
Finding a good doctor is like finding a good nail technician – people want a personal referral from someone they trust. If you’re still looking for Dr. Right, here are some suggestions from physicians and nail techs who’ve made referral relationships work.
Keywords: building your clientele business building working with doctors
February 1, 2000
| Article
October 1, 1999
| Article
August 1, 1999
| Article
By definition, pterygium forms if there is scar tissue in the nail matrix. Since the nail matrix at that particular site cannot manufacture nail plate, the proximal nail fold skin grows out with the skin of the nail bed, giving rise to the triangular formation known as pterygium.
